Table 2 Linear regression with random effects of patient and physician assessments of global Disease activity. G-DAS, global disease activity scale; BMI, body mass index (kg/m2); CRP, C-reactive protein; HAQ, health assessment questionnaire; NRS, numeric rating scale; CI (95%) 95% Confidence interval
G-DAS patients | G-DAS physicians | |||||
|---|---|---|---|---|---|---|
Estimates | CI (95%) | p | Estimates | CI (95%) | p | |
(Intercept) | -0.31 | -2.51–1.89 | 0.785 | 1.78 | 0.63–2.94 | 0.003 |
Age | 0.00 | -0.02–0.02 | 0.928 | -0.01 | -0.02–0.00 | 0.263 |
BMI | 0.01 | -0.03–0.06 | 0.577 | 0.00 | -0.02–0.02 | 0.918 |
Sex [female] | 0.09 | -0.42–0.59 | 0.734 | -0.00 | -0.26–0.25 | 0.979 |
G-DAS physicians | 0.04 | -0.06–0.14 | 0.412 | |||
G-DAS patients | 0.01 | -0.02–0.05 | 0.407 | |||
HAQ-Score | 0.27 | 0.00–0.53 | 0.048 | 0.01 | -0.13–0.16 | 0.870 |
Physical well-being (NRS 0–10) | 0.24 | 0.18–0.31 | < 0.001 | 0.05 | 0.01–0.09 | 0.010 |
Psychological well-being (NRS 0–10) | 0.11 | 0.06–0.16 | < 0.001 | 0.01 | -0.02–0.04 | 0.377 |
Pain last 7 days (NRS 0–10) | 0.42 | 0.38–0.47 | < 0.001 | 0.02 | -0.01–0.05 | 0.143 |
Disease duration | 0.02 | -0.02–0.06 | 0.335 | 0.01 | -0.01–0.04 | 0.186 |
CRP (mg/dl) | -0.11 | -0.18 – -0.05 | 0.010 | 0.04 | 0.00–0.08 | 0.028 |